In crucial win, bluebird nabs a second FDA committee endorsement - The Business Journals

... (we model peak sales of $38M), the unanimous AdComm vote is a much-needed win for BLUE's ex vivo gene therapy pipeline," they wrote.
https://www.google.com/url?rct=j&sa=t&url=https://www.bizjournals.com/boston/news/2022/06/10/in-crucial-win-bluebird-nabs-a-second-fda-committ.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw3coUMk47lq_h7q-REnAFdy